LAG3 and melanoma: LAG-3 positive T cells are present amongst tumor-infiltrating leukocytes within melanoma, leading to the hypothesis that inhibition of LAG-3/MHC II binding will result in improved immune response, T cell proliferation, and ultimately immune destruction of melanoma cells [51].